Loading…

Salivary gland cancer in Finland 1991-96: an evaluation of 237 cases

Conclusion In this material consisting of various salivary gland carcinomas, stage I, male gender and age were the most powerful predictors of patient outcome. Objectives To retrieve the records of all salivary gland cancer (SGC) patients diagnosed in Finland between 1991 and 1996 and to evaluate th...

Full description

Saved in:
Bibliographic Details
Published in:Acta oto-laryngologica 2005-02, Vol.125 (2), p.207-214
Main Authors: Luukkaa, Heikki, Klemi, Pekka, Leivo, Ilmo, Koivunen, Petri, Laranne, Jussi, Mäkitie, Antti, Virtaniemi, Jukka, Hinkka, Susanna, Grénman, Reidar
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Conclusion In this material consisting of various salivary gland carcinomas, stage I, male gender and age were the most powerful predictors of patient outcome. Objectives To retrieve the records of all salivary gland cancer (SGC) patients diagnosed in Finland between 1991 and 1996 and to evaluate the incidence, histological type and location of SGC, the treatment given and the outcome. Material and methods The records for all SGCs (n=286) diagnosed in Finland between 1991 and 1996 and reported to the Finnish Cancer Registry were retrieved. The histological re-evaluation and retrospective study involved 237 SGC patients. Results The study population consisted of 125 males and 112 females. The mean age was 59 years (males 61 years, females 58 years). Follow-up was at least 5 years. The commonest tumor location was the parotid gland (n=152; 64%), followed by the minor salivary glands (n=46; 19%), the submandibular gland (n=38; 16%) and the sublingual gland (n=1; 0.4%). The most frequent histological types of SGC were adenoid cystic carcinoma (n=65; 27%), mucoepidermoid carcinoma (n=45; 19%) and acinic cell carcinoma (n=41; 17%). Surgery, either alone or in combination with other treatment modalities, was used in 209 cases (88%). Radiotherapy was given to 136 patients (57%), 13 of whom (5%) did not undergo surgery. The 5-year overall survival rate was 56.5%, and for stages I-IV it was 78%, 25%, 21% and 23%, respectively (p
ISSN:0001-6489
1651-2251
DOI:10.1080/00016480510003174